Every SEC Form 3/4/5 on record for this filer (CIK 1284934) — 3 issuers, 14 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| NRXP | NRX Pharmaceuticals, Inc. | CHIEF FINANCIAL OFFICER · lapsed | 2022-06-29 → 2022-12-19 | 4 | $69,430 |
| PDSB | PDS Biotechnology Corp | Chief Financial Officer · lapsed | 2021-01-06 → 2021-06-17 | 3 | $150,000 |
| REFR | RESEARCH FRONTIERS INC | CFO & VP-Business Development · lapsed | 2016-01-04 → 2020-02-24 | 8 | $4,600 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| NRXP | 2022-12-16 | Buy | 30,000 | $1.10 | $33,000 | 46,337 |
| NRXP | 2022-11-25 | Buy | 8,716 | $1.12 | $9,762 | 8,716 |
| NRXP | 2022-11-25 | Buy | 600 | $1.10 | $660 | 9,316 |
| NRXP | 2022-11-25 | Buy | 7,021 | $1.11 | $7,793 | 16,377 |
| NRXP | 2022-11-25 | Buy | 7,021 | $1.11 | $7,793 | 16,337 |
| NRXP | 2022-11-25 | Buy | 8,716 | $1.12 | $9,762 | 8,716 |
| NRXP | 2022-11-25 | Buy | 600 | $1.10 | $660 | 9,316 |
| PDSB | 2021-06-15 | Buy | 17,647 | $8.50 | $150,000 | 17,647 |
3 of 3 issuers are covered and open a security page; the rest are on file here only.
